Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor–Positive Breast Cancer
2021 · JAMA Network Open · 33 citations
https://doi.org/10.1001/jamanetworkopen.2021.6322
N
Neil Carleton
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
910
Citations
17
h-index
21
i10-index
Neil Carleton is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Breast Cancer Treatment Studies & Single-cell and spatial transcriptomics. The author has an h-index of 17, co-authored 92 publications.
ORCID: 0000-0001-6985-7510Papers by this author
worksPersonalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
2022 · The Lancet Healthy Longevity · 23 citations
https://doi.org/10.1016/s2666-7568(21)00280-4
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials
2024 · JNCI Journal of the National Cancer Institute · 6 citations
https://doi.org/10.1093/jnci/djae188
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
2025 · Nature Cancer · 4 citations
https://doi.org/10.1038/s43018-025-00969-4
Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer
2025 · Breast Cancer Research · 2 citations
https://doi.org/10.1186/s13058-025-02014-9
Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs
2026 · npj Breast Cancer · 0 citations
https://doi.org/10.1038/s41523-026-00912-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat